三氧化二砷治疗后急性早幼粒细胞白血病患者的父母身份：病例系列研究。
Parenthood in patients with acute promyelocytic leukemia after treatment with arsenic trioxide: a case series.
机构信息
Disease Management Group, Tata Memorial Centre, Mumbai, India.
出版信息
Leuk Lymphoma. 2012 Nov;53(11):2192-4. doi: 10.3109/10428194.2012.679936. Epub 2012 Apr 30.
Arsenic trioxide, believed to be a carcinogen and a teratogen, has found its niche in the treatment of acute promyelocytic leukemia (APL). APL is a disease affecting young patients. Post-treatment fertility and outcome of pregnancy are always a concern in a disease with high cure rates. We report a case series of six patients who were treated successfully for APL with arsenic trioxide and who parented at least one healthy offspring after completing their treatment.
三氧化二砷，被认为是一种致癌剂和致畸剂，在治疗急性早幼粒细胞白血病（APL）方面找到了自己的位置。APL 是一种影响年轻患者的疾病。在高治愈率的疾病中，治疗后的生育能力和妊娠结局一直是人们关注的问题。我们报告了一系列成功接受三氧化二砷治疗 APL 的六例患者，他们在完成治疗后至少生育了一个健康的后代。
Zotero 插件